Regeneron Chief Scientific Officer George Yancopoulos joins Bloomberg's Katie Greifeld at the annual JP Morgan healthcare conference in San Francisco to talk about the FDA's response to their hearing ...

Hearing loss can stem from both genetic and non-genetic factors. Genetics contributes to a significant portion of congenital hearing loss in babies. As people age, they may experience a gradual ...

Hearing loss symptoms can range from difficulty understanding speech and locating sounds to requiring a high volume when watching television or listening to music. You can experience hearing loss at ...

Differentiation of induced pluripotent stem cells (iPSCs) toward neuronal lineages has enabled diverse cellular models of human neurodevelopment and related disorders. Here, we jointly profiled ...

Background: This study aimed to evaluate and compare demographic, periodontal, and cardiac parameters; Dickkopf-3 (DKK-3; rs11544817) and complement factor H (CFH; rs10737680) protein levels; and gene ...

Genetic hearing loss has been found to be caused by a mutation in the CPD gene—a regulator of metabolic signaling that is involved with inner ear functions. Mice with CPD mutations displayed hearing ...

Hearing loss was associated with smaller brain volumes and a 71% higher risk for dementia, particularly in individuals carrying the apolipoprotein E (APOE) epsilon 4 (APOEε4) allele, new research ...

Up to 60% of congenital and early-onset hearing loss is caused by genetic mutations in an inherited gene, and gene therapy has recently emerged as a potential treatment option. To provide a ...

Up to 60% of congenital and early-onset hearing loss is caused by genetic mutations in an inherited gene, and gene therapy has recently emerged as a potential treatment option. To provide a ...

Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy is being evaluated for profound genetic hearing loss due ...